Literature DB >> 30204878

Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge.

Kelly R Reveles1,2, Kierra M Dotson3, Anne Gonzales-Luna3, Dhara Surati3, Bradley T Endres3, M Jahangir Alam3, Kevin W Garey3.   

Abstract

BACKGROUND: Clostridioides (formerly Clostridium) difficile infection (CDI) is associated with significant morbidity and mortality, including frequent hospitalizations. However, the impact of CDI after hospital discharge is poorly understood. The purpose of this study was to assess patient discharge disposition and understand CDI-related risk factors for nonhome discharge.
METHODS: Using a nationally representative database of Veterans Health Administration (VHA) patients (2003-2014) and a validation database from hospitalized non-VHA patients in Houston, Texas, admission and discharge disposition was obtained for patients with CDI and matched controls. Incidence of and clinical/microbiologic risk factors for nonhome discharge were assessed using these databases.
RESULTS: A total of 15173 VHA patients with CDI and 48599 non-CDI control patients originally admitted from the community were included. Significantly more patients with CDI were discharged to a nonhome location compared with controls (18% vs 8%; P < .0001), most commonly hospice/death (12%) or nursing home/long-term care facility (6%). Results were confirmed using a propensity-matched analysis and a validation cohort of 1941 hospitalized patients with CDI in Houston, Texas. Age, comorbidities, severe CDI, and ribotypes F027, F001, and F053-163 were associated with a nonhome discharge (P < .05 for all).
CONCLUSIONS: Hospitalized patients with CDI frequently required a higher level of medical care residence at discharge compared with non-CDI patients. Risk factors for discharge to a higher level of care included CDI disease severity and variables associated with recurrent CDI.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anaerobic infections; epidemiology; healthcare-associated infections; outcomes research; strain typing

Year:  2019        PMID: 30204878      PMCID: PMC6522682          DOI: 10.1093/cid/ciy782

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infection.

Authors:  S Sethi; K W Garey; V Arora; S Ghantoji; P Rowan; M Smolensky; H L DuPont
Journal:  J Hosp Infect       Date:  2010-12-28       Impact factor: 3.926

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

4.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

5.  Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection?

Authors:  R Ricciardi; J Nelson; J L Griffith; T W Concannon
Journal:  J Hosp Infect       Date:  2011-12-01       Impact factor: 3.926

6.  Clostridium difficile outbreak strain BI is highly endemic in Chicago area hospitals.

Authors:  Stephanie R Black; Kingsley N Weaver; Roderick C Jones; Kathleen A Ritger; Laurica A Petrella; Susan P Sambol; Michael Vernon; Stephanie Burton; Sylvia Garcia-Houchins; Stephen G Weber; Mary Alice Lavin; Dale Gerding; Stuart Johnson; Susan I Gerber
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09       Impact factor: 3.254

7.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.

Authors:  Lynne V McFarland; Gary W Elmer; Christina M Surawicz
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

8.  Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

Authors:  Derrick W Crook; A Sarah Walker; Yin Kean; Karl Weiss; Oliver A Cornely; Mark A Miller; Roberto Esposito; Thomas J Louie; Nicole E Stoesser; Bernadette C Young; Brian J Angus; Sherwood L Gorbach; Timothy E A Peto
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

9.  Predictors of first recurrence of Clostridium difficile infection: implications for initial management.

Authors:  David W Eyre; A Sarah Walker; David Wyllie; Kate E Dingle; David Griffiths; John Finney; Lily O'Connor; Alison Vaughan; Derrick W Crook; Mark H Wilcox; Timothy E A Peto
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

10.  Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients.

Authors:  Erik R Dubberke; Anne M Butler; Kimberly A Reske; Denis Agniel; Margaret A Olsen; Gina D'Angelo; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more
  10 in total

1.  Body mass index and risk of clostridioides difficile infection: a systematic review and meta-analysis.

Authors:  Nipith Charoenngam; Ben Ponvilawan; Jerapas Thongpiya; Pitchaporn Yingchoncharoen; Thanat Chaikijurajai; Natapat Chaisidhivej; Caroline M Apovian; Patompong Ungprasert
Journal:  Infection       Date:  2022-01-05       Impact factor: 3.553

2.  Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.

Authors:  Masaad Saeed Almutairi; Anne J Gonzales-Luna; Faris S Alnezary; Saad B Fallatah; M Jahangir Alam; Khurshida Begum; Kevin W Garey
Journal:  Anaerobe       Date:  2021-08-27       Impact factor: 3.331

3.  Impact of the Introduction of a Two-Step Laboratory Diagnostic Algorithm in the Incidence and Earlier Diagnosis of Clostridioides difficile Infection.

Authors:  Nieves Sopena; Jun Hao Wang-Wang; Irma Casas; Lourdes Mateu; Laia Castellà; María José García-Quesada; Sara Gutierrez; Josep M Llibre; M Luisa Pedro-Botet; Gema Fernandez-Rivas
Journal:  Microorganisms       Date:  2022-05-23

4.  Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection.

Authors:  Travis J Carlson; Anne J Gonzales-Luna; Kimberly Nebo; Hannah Y Chan; Ngoc-Linh T Tran; Sheena Antony; Chris Lancaster; M Jahangir Alam; Khurshida Begum; Kevin W Garey
Journal:  Open Forum Infect Dis       Date:  2020-10-07       Impact factor: 3.835

Review 5.  Clostridioides difficile therapeutics: guidelines and beyond.

Authors:  Robert Orenstein; Roberto L Patron
Journal:  Ther Adv Infect Dis       Date:  2019-08-13

6.  Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study.

Authors:  Richard L Hengel; Timothy E Ritter; Ramesh V Nathan; Lucinda J Van Anglen; Claudia P Schroeder; Ryan J Dillon; Stephen W Marcella; Kevin W Garey
Journal:  Open Forum Infect Dis       Date:  2020-03-19       Impact factor: 3.835

7.  Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection.

Authors:  Travis J Carlson; Bradley T Endres; Julie Le Pham; Anne J Gonzales-Luna; Faris S Alnezary; Kimberly Nebo; Julie Miranda; Chris Lancaster; Eugénie Bassères; Khurshida Begum; M Jahangir Alam; Kelly R Reveles; Kevin W Garey
Journal:  Open Forum Infect Dis       Date:  2020-01-04       Impact factor: 3.835

Review 8.  Transitions of care in Clostridioides difficile infection: a need of the hour.

Authors:  Sahil Khanna; James Lett; Cheri Lattimer; Glenn Tillotson
Journal:  Therap Adv Gastroenterol       Date:  2022-02-28       Impact factor: 4.409

9.  Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.

Authors:  Anne J Gonzales-Luna; Jennifer K Spinler; Numan Oezguen; Md Abdul Wadud Khan; Heather A Danhof; Bradley T Endres; M Jahangir Alam; Khurshida Begum; Chris Lancaster; Gabriela Pd Costa; Tor C Savidge; Julian G Hurdle; Robert Britton; Kevin W Garey
Journal:  Anaerobe       Date:  2021-05-24       Impact factor: 2.837

10.  GABAergic but not Antidepressant Medications Increase Risk for Clostridioides difficile Infection in a National Cohort of Veterans.

Authors:  Falak Lalani; Eric H Young; Rupesh M Panchal; Kelly R Reveles
Journal:  Open Forum Infect Dis       Date:  2020-08-13       Impact factor: 3.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.